Search - tctmd.com

Presenter: Ivan Gomez Blazquez, Emiliano Fdez-Obanza, Victor A. Jimenez Diaz, Jorge Sep?lveda, Antonio De Miguel Castro, Guillermo Bastos Fern?ndez, Josu? Ponce Bustillo, Alberto Ortiz Saez, Jose A. Baz Alonso, Andres I?iguez

January 31, 2013

News Daily News

Ideal Duration of Dual Antiplatelet Therapy May Depend on Stent Type

Jason Kahn

January 22, 2013

News Daily News

EES Outperform First-Generation DES in Treatment of CTOs

L.A. McKeown

December 27, 2012

News Daily News

Real-World Equivalence Seen for Zotarolimus- and Everolimus-Eluting Stents

Caitlin E. Cox

December 26, 2012

News Daily News

Extended Dual Antiplatelet Therapy Lowers Death, MI Rates in DES Patients

Jason Kahn

December 05, 2012

News Daily News

Study Shows Impact of Public Health Communication on Clopidogrel Use Post DES

November 20, 2012

News Daily News

BELLO: Drug-Coated Balloons Take on De Novo Lesions vs. DES

Caitlin E. Cox

November 15, 2012

Advertisement

Paclitaxel-eluting Balloon Matches Taxus for Treating DES Restenosis

COMFORTABLE-AMI: Biodegradable-Polymer DES Offers Lasting Benefit to STEMI Patients

Novel Stent Helps Treat Bifurcation Lesions in FIM Registry

DESolve Nx: Bioresorbable DES Shows Positive Results at 6 Months

Most Deaths Within 30 Days After PCI Not a Direct Result of Procedure

TWENTE: Still Few Differences between ZES and EES at 2 Years

Mortality Varies by Revascularization Method in Dialysis Patients

Stent Complications: Restenosis and Thrombosis

Study Looks at Adding Corticosteroid Treatment to Bare-Metal Stenting

BIOSOLVE-1 Shows Improvement in Paclitaxel-Eluting Bioabsorbable Stent

Is Nobori NEXT? Biodegradable-Polymer DES Noninferior to EES

Pair of Studies Show Positive Stent Results at ACC

ISAR-DESIRE 3 Published: Paclitaxel-Eluting Balloons Match PES for DES Restenosis

Profile and Outcome of Very Late Bare Metal Stent Thrombosis Treated With Percutaneous Coronary Intervention

Ideal Duration of Dual Antiplatelet Therapy May Depend on Stent Type

EES Outperform First-Generation DES in Treatment of CTOs

Real-World Equivalence Seen for Zotarolimus- and Everolimus-Eluting Stents

Extended Dual Antiplatelet Therapy Lowers Death, MI Rates in DES Patients

Study Shows Impact of Public Health Communication on Clopidogrel Use Post DES

BELLO: Drug-Coated Balloons Take on De Novo Lesions vs. DES

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content